Advertisement

Infection

, Volume 47, Issue 1, pp 67–75 | Cite as

Health-related quality of life in patients with alveolar echinococcosis: a cross-sectional study

  • Julian SchmidbergerEmail author
  • Henriette Weimer
  • Patrycja Schlingeloff
  • Wolfgang Kratzer
  • Beate Grüner
  • Echinococcosis Working Group, Ulm
Original Paper
  • 56 Downloads

Abstract

Purpose

The Alveolar echinococcosis (AE) is a rare zoonosis caused by the parasite Echinococcus multilocularis. To date, nothing is known about the health-related quality of life (HRQoL) in patients with AE. The aim of the study was to evaluate the HRQoL in patients with AE in comparison of the healthy population.

Methods

We used the 36-Item Short Form Health Survey (SF-36) questionnaire to evaluate the HRQoL. The SF-36 scales have a range of 0–100 (0 represents the worst and 100 the most favourable state of health). SAS Version 9.2 was used for the statistical analysis of AE-cases (n = 30) and the healthy control group (n = 35).

Results

The analysis showed that the HRQoL in people with AE is reduced in comparison with the control population. The study group consisted of 15 (50.0%) men and 15 (50.0%) women; the control group of 16 (45.7%) men and 19 (54.3%) women. The mean age was 55.73 ± 16.65 years, while that of the control group was 54.57 ± 15.34 years. The physical quality of life in patients with AE (45.21 ± 11.42) was not significantly less than that of the control group (50.54 ± 10.52); p = 0.0568. Nevertheless, AE-patients show lower SF-36 scores for the physical quality of life. For the mental quality of life, patients with AE had a significantly lower score (45.46 ± 10.57) than the control group (51.57 ± 9.04); p = 0.0154.

Conclusions

The HRQoL in people with AE is reduced in comparison with a control population. Assessment of the physical and mental quality of life in patients with AE may help to evaluate the patient outcome.

Keywords

Alveolar echinococcosis Echinococcus multilocularis Health-related quality of life Healthy control group SF-36 questionnaire 

Notes

Acknowledgements

Members of the echinococcosis working group: Thomas FE Barth, Sven Baumann, Doris Henne-Bruns, Tilmann Gräter, Andreas Hillenbrand, Tanja Kaltenbach, Frauke Theis.

Funding

The results are from a German Research Foundation (DFG) funded project called “Establishment of a national database for alveolar echinococcosis” (Ref. No. KA 4356/3-1).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The study was approved by the local Ethics Committee approval and the Declaration of Helsinki (ref. No. 63/18).

References

  1. 1.
    Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefGoogle Scholar
  2. 2.
    Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis. 2009;13:125–33.CrossRefGoogle Scholar
  3. 3.
    Romig T, Kratzer W, Kimmig P, Frosch M, Gaus W, Flegel WA, Gottstein B, Lucius R, Beckh K, Kern P. An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg. 1999;61:566–73.CrossRefGoogle Scholar
  4. 4.
    Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of alveolar echinococcosis. PLoS Negl Trop Dis. 2010;4(6):e722.CrossRefGoogle Scholar
  5. 5.
    Deplazes P, Rinaldi L, Alvarez Rojas CA, Torgerson PR, Harandi MF, Romig T, Antolova D, Schurer JM, Lahmar S, Cringoli G, Magambo J, Thompson RC, Jenkins EJ. Global distribution of alveolar and cystic echinococcosis. Adv Parasitol. 2017;95:315–493.CrossRefGoogle Scholar
  6. 6.
    Craig PS, Deshan L, MacPherson CN, Dazhong S, Reynolds D, Barnish G, Gottstein B, Zhirong W. A large focus of alveolar echinococcosis in central China. Lancet. 1992;340:826–31.CrossRefGoogle Scholar
  7. 7.
    Craig PS. Echinococcus multilocularis. Curr Opin Infect Dis. 2003;16:437–44.CrossRefGoogle Scholar
  8. 8.
    Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, Wen H, McManus DP. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People’s Republic of China. Acta Trop. 2015;141:235–43.CrossRefGoogle Scholar
  9. 9.
    Craig PS. Epidemiology of human alveolar echinococcosis in China. Parasitol Int. 2006;55:221–5.CrossRefGoogle Scholar
  10. 10.
    Tiaoying L, Jiamin Q, Wen Y, Craig PS, Xingwang C, Ning X, Ito A, Giraudoux P, Wulamu M, Wen Y, Schantz PM. Echinococcosis in Tibetan populations, western Sichuan Province, China. Emerg Infect Dis. 2005;11:1866–73.CrossRefGoogle Scholar
  11. 11.
    Schmidberger J, Kratzer W, Stark K, Grüner B. Alveolar echinococcosis in Germany, 1992–2016. An update based on the newly established national AE database. Infection. 2018;46:197–206.CrossRefGoogle Scholar
  12. 12.
    Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am. 1996;25:655–89.CrossRefGoogle Scholar
  13. 13.
    Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev. 2004;17:107–35.CrossRefGoogle Scholar
  14. 14.
    Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, Kull T, Barth TF, Kern P, Gruener B. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016;22:3621–31.CrossRefGoogle Scholar
  15. 15.
    Kern P, Ammon A, Kron M, Sinn G, Sander S, Petersen LR, Gaus W, Kern P. Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis. 2004;10:2088–93.Google Scholar
  16. 16.
    Piarroux M, Piarroux R, Knapp J, Bardonnet K, Dumortier J, Watelet J, Gerard A, Beytout J, Abergel A, Bresson-Hadni S, Gaudart J. Populations at risk for alveolar echinococcosis, France. Emerg Infect Dis. 2013;19:721–8.CrossRefGoogle Scholar
  17. 17.
    Kreidl P, Allerberger F, Judmaier G, Auer H, Aspöck H, Hall AJ. Domestic pets as risk factors for alveolar hydatid disease in Austria. Am J Epidemiol. 1998;147:978–81.CrossRefGoogle Scholar
  18. 18.
    Lass A, Szostakowska B, Myjak P, Korzeniewski K. Fresh fruits, vegetables and mushrooms as transmission vehicles for Echinococcus multilocularis in highly endemic areas of Poland: reply to concerns. Parasitol Res. 2016;115:3637–42.CrossRefGoogle Scholar
  19. 19.
    Conraths FJ, Probst C, Possenti A, Boufana B, Saulle R, La Torre G, Busani L, Casulli A. Potential risk factors associated with human alveolar echinococcosis: systematic review and meta-analysis. PLoS Negl Trop Dis. 2017;11:e0005801.CrossRefGoogle Scholar
  20. 20.
    Bresson-Hadni S, Laplante JJ, Lenys D, Rohmer P, Gottstein B, Jacquier P, Mercet P, Meyer JP, Miguet JP, Vuitton DA. Seroepidemiologic screening of echinococcus multilocularis infection in a European area endemic for alveolar echinococcosis. Am J Trop Med Hyg. 1994;51:837–46.CrossRefGoogle Scholar
  21. 21.
    Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, Reske SN, Kern P. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology. 2004;39:509–17.CrossRefGoogle Scholar
  22. 22.
    Nunnari G, Pinzone MR, Gruttadauria S, Celesia BM, Madeddu G, Malaguarnera G, Pavone P, Cappellani A, Cacopardo B. Hepatic echinococcosis: clinical and therapeutic aspects. World J Gastroenterol. 2012;18:1448–58.CrossRefGoogle Scholar
  23. 23.
    Vuitton DA. Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? Expert Rev Anti Infect Ther. 2009;7:145–9.CrossRefGoogle Scholar
  24. 24.
    Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother. 2000;46:451–6.CrossRefGoogle Scholar
  25. 25.
    Torgerson PR, Schweiger A, Deplazes P, Pohar M, Reichen J, Ammann RW, Tarr PE, Halkik N, Müllhaupt B. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol. 2008;49:72–7.CrossRefGoogle Scholar
  26. 26.
    King CH. Health metrics for helminth infections. Acta Trop. 2015;141:150–60.CrossRefGoogle Scholar
  27. 27.
    King CH, Bertino AM. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis. 2008;2:e209.CrossRefGoogle Scholar
  28. 28.
    Bullinger M. Das Konzept der Lebensqualität in der Medizin: Entwicklung und heutiger Stellenwert. Lebensqualität im Gesundheitswesen: Wissen wir, was wir tun? (2013).Google Scholar
  29. 29.
    Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung: Hogrefe Verlag für Psychologie Göttingen; 1998.Google Scholar
  30. 30.
    Ellert U, Kurth BM. Gesundheitsbezogene Lebensqualität bei Erwachsenen in Deutschland. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2013;56(5–6):643–9.CrossRefGoogle Scholar
  31. 31.
    Weltgesundheitsorganisation. Bangkok Charta für Gesundheitsförderung in einer globalisierten Welt. 2005. http://www.who.int/healthpromotion/conferences/6gchp/BCHP_German_version.pdf. Accessed 17 Sept 2018.
  32. 32.
    Brunetti E, Kern P, Vuitton DA. Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010 114(1):1–16.  https://doi.org/10.1016/j.actatropica.2009.11.001. (Epub 2009 Nov 30).CrossRefGoogle Scholar
  33. 33.
    Fang S, Shen X, Chen AJ, Li S, Shan K. Health-related quality of life in patients with primary cutaneous amyloidosis. PLoS One. 2015;10:e0120623.CrossRefGoogle Scholar
  34. 34.
    Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK, Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health Qual Life Outcomes. 2017;15:148.CrossRefGoogle Scholar
  35. 35.
    Sileshi L, Tefera E. Health-related quality of life of mothers of children with congenital heart disease in a sub-Saharan setting: cross-sectional comparative study. BMC Res Notes. 2017;10:513.CrossRefGoogle Scholar
  36. 36.
    Kalter J, Verdonck-de Leeuw IM, Sweegers MG, Aaronson NK, Jacobsen PB, Newton RU, Courneya KS, Aitken JF, Armes J, Arving C, Boersma LJ, Braamse AM, Brandberg Y, Chambers SK, Dekker J, Ell K, Ferguson RJ, Gielissen MF, Glimelius B, Goedendorp MM, Graves KD, Heiney SP, Horne R, Hunter MS, Johansson B, Kimman ML, Knoop H, Meneses K, Northouse LL, Oldenburg HS, Prins JB, Savard J, van Beurden M, van den Berg SW, Brug J, Buffart LM. Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: an individual patient data meta-analysis of 22 RCTs. Psychooncology. 2018;27:1150–61.CrossRefGoogle Scholar
  37. 37.
    Schmidberger J. Influence of self-help on health-relevant quality of life—a study in dialysis patients with end-stage renal disease. Dialyse Aktuell. 2016;20:95–100.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Internal Medicine IUlm University HospitalUlmGermany
  2. 2.Department of Internal Medicine IIIUlm University HospitalUlmGermany

Personalised recommendations